Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau, IIB Sant Pau, Barcelona, Spain; Foundation Centre for Osteopathic Medicine Collaboration, Spain National Centre, Barcelona, Spain.
Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau, IIB Sant Pau, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
J Clin Epidemiol. 2020 May;121:32-44. doi: 10.1016/j.jclinepi.2020.01.006. Epub 2020 Jan 20.
The aim of this review was to evaluate a selection of major reporting aspects in manual therapy (MT) trials, before and after the publication of the CONSORT extension for nonpharmacological trials (CONSORTnpt) STUDY DESIGN AND SETTING: We randomly selected 100 MT trials published between 2000 and 2015 and divided them into a pre-CONSORTnpt (n = 50) and a post-CONSORTnpt (n = 50) group. We extracted data on relevant issues of internal validity, reliability, and description of interventions. Two authors extracted data independently. Percentages were used for descriptive analyses, and Fisher's exact test and the chi-square test were used for group comparisons.
Six different types of MT interventions with up to 20 controls were analyzed. The most common populations/conditions studied were healthy subjects and subjects with lower back or neck pain. Over 70% of studies included multi-session interventions, and 42% of studies reported long-term followup. The only significant differences between groups were the inclusion of a flowchart diagram, the estimated effect size, precision descriptions, and the description of intervention procedures.
Our findings suggest that trials in MT show poor reporting even after the availability of standardized guidelines.
本综述旨在评估手法治疗（MT）试验在 CONSORT 非药物试验扩展版（CONSORTnpt）发布前后主要报告方面的选择。
我们随机选择了 2000 年至 2015 年间发表的 100 项 MT 试验，并将其分为 CONSORTnpt 前（n=50）和 CONSORTnpt 后（n=50）组。我们提取了与内部有效性、可靠性和干预措施描述相关的问题的数据。两位作者独立提取数据。使用百分比进行描述性分析，Fisher 确切检验和卡方检验用于组间比较。
分析了 6 种不同类型的 MT 干预措施，最多有 20 个对照。最常见的研究人群/病症是健康受试者和下背部或颈部疼痛的受试者。超过 70%的研究包括多疗程干预，42%的研究报告了长期随访。仅在流程图图表、估计的效应大小、精确描述和干预程序描述方面存在组间的显著差异。
即使有了标准化指南，MT 试验的报告仍然很差。
